According to The Insight Partners – The global molecular diagnostics landscape is undergoing a profound evolution, with digital PCR (dPCR) and real-time PCR (qPCR) technologies at the center of this transformation. According to a detailed market analysis by The Insight Partners, the digital PCR and real-time PCR market is projected to grow significantly by 2031, registering a CAGR of 9.1% during 2025–2031, with the development of droplet digital PCR expected to bring new trends to the market in the coming years.
Digital PCR and Real-Time PCR Market Overview
The market for dPCR and qPCR is witnessing high growth, fueled by the growing need for accurate and sensitive diagnostic instruments in molecular biology. Both technologies are essential for the detection and measurement of nucleic acids such as DNA and RNA, playing a critical role in genetic studies, pathogen identification, and cancer research.
Improvements in dPCR, especially chip and droplet-based technology, have increased sensitivity and precision, making it a preferred choice for clinical diagnostics. Meanwhile, qPCR is gaining popularity for its ability to offer real-time monitoring of amplification, a key requirement for time-sensitive applications.
The increasing incidence of genetic diseases and infectious diseases further drives the demand for these molecular methods, providing tremendous scope for innovation and investment. The Asia Pacific region is emerging as a particularly lucrative market, driven by high unmet clinical needs, increasing healthcare expenditure, and untapped opportunities.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00018009
Key Growth Drivers
Rising Investments in Gene Synthesis and PCR Technologies: Significant funding activity is accelerating market momentum. In 2024, Stilla Technologies, a startup leading innovation in digital PCR, raised US$ 26.5 million in Series C funding to accelerate the commercialization of its digital PCR platform. Such investments are reinforcing the industry’s long-term growth trajectory.
Technological Breakthroughs: Innovation continues to reshape PCR capabilities. In March 2023, researchers at the Korea Institute of Science and Technology announced the development of an ultrafast PCR technology utilizing photothermal nanomaterials that reduces test duration by ten times compared to previous methods, completing results in just 5 minutes.
Growing Adoption in Emerging Countries: PCR has evolved as a key diagnostic technology in developing nations, enabling healthcare professionals to diagnose a wide range of infectious diseases accurately. Due to its simple, rapid, and highly specific screening capabilities, demand for digital PCR and real-time PCR is expected to increase significantly in developing countries.
Segmentation Insights
The reagents and consumables segment held the largest share of the market in 2024 and is expected to register significant growth through 2031. By application, infectious diseases testing held the largest share in 2024, while by end user, hospitals and diagnostic centers dominated the market. On the technology front, the real-time PCR segment held a larger share of the market in 2024, though digital PCR is gaining ground due to its unmatched accuracy in detecting low-abundance DNA and RNA sequences.
Regional Landscape
North America dominated the digital PCR and real-time PCR market in 2024, supported by a well-established healthcare system, significant government funding, and continuous advancements in biotechnology. PCR technology plays a vital role in early cancer detection, identifying genetic mutations, and monitoring treatment response in the region.
Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00018009
Competitive Landscape and Recent Developments
Key companies in the market include QIAGEN NV, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Agilent Technologies Inc, bioMerieux SA, Danaher Corp, and Abbott Laboratories, among others.
Recent activity signals continued consolidation. Bio-Rad Laboratories announced it had entered into a binding offer to acquire all equity interests in Stilla Technologies, with the deal expected to close by the end of the third quarter of 2025.
Outlook
The digital PCR and real-time PCR market stands at an exciting inflection point. As precision medicine, oncology diagnostics, and infectious disease surveillance continue to grow in importance globally, these technologies will remain indispensable tools for researchers and clinicians alike — driving robust market expansion well into the next decade.
Related Reports @
Cell Dissociation Market Revenue and Demand Analysis: Growth Forecast till 2031
Single-Cell Analysis Market Overview, Growth, and Development 2031 by Top Players
Life Science Reagents Market Size and Growth 2031
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
